Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02727023 · ClinicalTrials.gov registry record · NA
Effect of OMM on Anandamide Levels in Saliva
A NA study, sponsored by New York Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02727023 is a NA study that has completed, run by New York Institute of Technology. The registered enrollment target is 2 participants.
The verdict
NCT02727023, a NA study, has completed, sponsored by New York Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The Investigators will be studying the effects of Osteopathic Manipulative Lymphatic Pump Treatment on levels of anandamide in Saliva. A qualitative scale will also be used to measure the canabinomimetic effects of osteopathic treatment.
Interventions
- OTHER Osteopathic Manipulative Medicine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-12 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02727023
The ClinicalTrials.gov registry entry for NCT02727023 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York Institute of Technology, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Osteopathic Manipulative Medicine is the first listed.
NCT02727023 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02727023 about?
NCT02727023 is a clinical study titled "Effect of OMM on Anandamide Levels in Saliva". The Investigators will be studying the effects of Osteopathic Manipulative Lymphatic Pump Treatment on levels of anandamide in Saliva. A qualitative scale will also be used to measure the canabinomimetic effects of osteopathic treatment.
What is the current status of trial NCT02727023?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2015-12. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02727023?
The interventions under investigation include: Osteopathic Manipulative Medicine (OTHER).
Who is sponsoring clinical trial NCT02727023?
This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.